European Union leaders have underscored the urgent need for enhanced collaboration among EU institutions, member states, and law enforcement agencies to tackle the bloc’s burgeoning illegal drug market, which is valued at approximately €31 billion annually. This pressing issue was a focal point during the EU summit in Brussels, illustrating the heightened concern over the ramifications of drug trafficking, organized crime, and the proliferation of new psychoactive substances throughout Europe.
Highlighting the cross-border nature of organized crime, Bart De Wever emphasized the necessity for a coordinated international response. He pointed out that nations with significant ports, like Belgium, have become prime targets for criminal networks exploiting global trade routes. In response, EU leaders have called for a comprehensive strategy that merges public health initiatives, security measures, crime prevention tactics, and international cooperation. This approach seeks to address all facets of the drug trade, from production and trafficking to consumption and rehabilitation.
EU leaders also expressed concerns about the increasingly sophisticated criminal networks that utilize encrypted communication platforms, online marketplaces, and intricate international supply chains to distribute illegal substances across Europe. To combat these challenges, the summit conclusions outlined a focus on bolstering preparedness, safeguarding public health, enhancing law enforcement capabilities, mitigating drug-related harm, and fostering expanded cooperation with international partners through efforts such as the European Coalition Against Drugs.
This discussion at the summit aligns with a recent agreement reached by EU home affairs ministers to implement the EU Drugs Strategy 2026–2030. This strategy is designed to improve coordination and confront emerging threats associated with illicit drugs and organized crime. By addressing these issues at such a high political level, the EU aims to develop a unified and effective response to the complex challenges posed by the illegal drug market.